Shopping Cart
- Remove All
- Your shopping cart is currently empty
AE-3763 is a peptide-based inhibitor of human neutrophil elastase with an IC50 of 29 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $1,190 | Backorder |
Description | AE-3763 is a peptide-based inhibitor of human neutrophil elastase with an IC50 of 29 nM. |
Targets&IC50 | Neutrophil elastase (human):29 nM |
In vitro | AE-3763 has potent inhibitory activity against human neutrophil elastase as well as extremely high solubility and stability in water. |
In vivo | The infusion of AE-3763 significantly inhibits edema and leukocyte infiltration into the lung and improves the survival rate by 24 hours in a mouse model of fatal shock with multiple organ dysfunction. AE-3763 dose-dependently prevents hemorrhage when administered intravenously by infusion (ED50: 0.42 mg/kg/h) or bolus injection (1.2 mg/kg). Preliminary studies indicate no overt toxic effects of AE-3763 (300 mg/kg, i.v.) in mice. |
Animal Research | D-Galactosamine shock is induced in C3H/HeN mice (6-7 w, 22-25 g). AE-3763 (10 or 100 mg/kg) is administrated intraperitoneally six times at 2 h interval. Control animals receive the vehicle (PBS) instead of AE-3763. The animal survival rate is observed up to 24 h after shock induction. |
Molecular Weight | 549.54 |
Formula | C23H34F3N5O7 |
Cas No. | 291778-77-3 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.